Immunosuppressor FK506 increases Endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells - Albiñana, V; Sanz-Rodríguez, F; Recio-Poveda, L (Mol Pharmacol, 2011)
et al.